Similarly, the reduction of UBR7 levels mediated by methyltransferase ALKBH5 reduces the transcription of Keap1, which in turn upregulates the Nrf2/BACH1/HK2 pathway, promoting tumorigenesis in hepatocellular carcinoma by targeting glycolysis [68]. The gene discussed is BACH1; the disease is hepatocellular carcinoma.